Atlas Trials

S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy

Clinical trial NCT00066612 · COMPLETED

Trial details

NCT number
NCT00066612
Sponsor
SWOG Cancer Research Network
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Start date
2003-07-01
Primary completion
2007-08-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.